Can psychedelic-assisted therapy be an effective treatment option for my major depression?

For major depression, the best-supported option currently is traditional antidepressants like selective serotonin reuptake inhibitors. A 2024 systematic review compared psychedelic-assisted therapy with open-label traditional antidepressants and found no efficacy advantage for the psychedelic approach ¹.

What the research says

The main issue in comparing these treatments is that psychedelic trials are almost always open-label, meaning patients know they are receiving the psychedelic. To be fair, researchers compared them with open-label traditional antidepressants rather than blinded ones. Under these conditions, the psychedelic approach did not outperform traditional antidepressants ¹.

Traditional antidepressants have long been the standard for treating major depression. They work by changing brain chemistry to improve mood and reduce symptoms. They are widely used and studied, making them a reliable first-line option for many patients ¹.

Other research shows that blood biomarkers for depression are hard to measure consistently because of many factors like age, sex, and lifestyle. This makes it difficult to find simple biological markers that can guide treatment choices right now ³.

Early psychological interventions can reduce the risk of developing major depression by about 43% at the end of treatment and 33% at one year. Shorter time without treatment is linked to better responses to therapy ⁴.

What to ask your doctor

• How do traditional antidepressants compare to psychedelic-assisted therapy for my specific case of major depression?
• What are the risks and side effects of psychedelic-assisted therapy versus standard antidepressants?
• Are there clinical trials or open-label studies I can review to see real-world outcomes?
• How would you monitor my progress if I chose psychedelic-assisted therapy versus medication?